OrthoPediatrics (KIDS) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $110M

Market Cap: $454.1MFounded: 2006HQ: Warsaw, United States

Sector Ranking#20 in Regenerative Medicine

Overview

OrthoPediatrics is a mission-driven medical device company focused solely on pediatric orthopedics, having established itself as the first and only public pure-play in this niche. Since its 2006 founding, it has built a comprehensive portfolio of over 70 systems across trauma, deformity correction, scoliosis, and sports medicine, impacting over 1.1 million children. Its strategy combines pediatric-specific product innovation with a deep commitment to clinical education and surgeon collaboration to drive growth in a historically underserved market.

Pediatric OrthopedicsTraumaDeformity CorrectionScoliosisSports Medicine

Technology Platform

A deep expertise in pediatric-specific design and systems engineering, producing fully integrated implant and instrument solutions tailored to children's anatomy and growth, augmented by a digital Enabling Technologies platform for smarter, evidence-based care.

Funding History

3

Total raised:$110M

IPO$75MUndisclosedOct 19, 2017

Series B$25MUndisclosedMar 15, 2017

Series A$10MUndisclosedJun 15, 2015

Opportunities

Significant white space exists in the underserved pediatric orthopedic device market, estimated at $2-3B globally.

OrthoPediatrics is poised to capture growth through conversion from adult implants, expansion into adjacent markets like specialty bracing (OPSB), and geographic international penetration, all supported by a strong clinical education moat.

Risk Factors

Key risks include the niche size of the core market potentially limiting scale, increased competitive attention from large orthopedic conglomerates, execution challenges in new business divisions (Enabling Tech, OPSB), and dependence on surgeon training and relationships for growth.

Competitive Landscape

Competes against large, diversified orthopedic giants (e.g., Stryker, Zimmer) with limited pediatric focus and smaller private niche players. OrthoPediatrics' advantages are its pure-play dedication, broadest pediatric-specific portfolio, and deep clinical education infrastructure, making it the category leader.